2024-03-15 12:12:42 ET
Summary
- Progyny, Inc. (PGNY) is recommended as a buy due to its potential for continued growth and positive long-term outlook.
- The recent weak share price is attributed to expected weak performance in 1Q24, but this is believed to be a temporary issue.
- PGNY's active pipeline is the largest it has ever been, indicating future growth opportunities, particularly in the women's health vertical.
Investment action
Read the full article on Seeking Alpha
For further details see:
Progyny: Long-Term Outlook Remains Positive, Reiterate Buy